Keywords: boeh, ing, re-ly, trial, completes, enrollment, german

Boeh Ing's RE-LY trial completes enrollment

Article | 21 January 2008

Print This

German drug major Boehringer Ingelheim has completed enrollment in its landmark RE-LY trial, which is evaluating the long-term efficacy and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in